Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 6721 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

Affidea enters into an agreement to acquire MedEuropa Romania

Read more ››
By: PR Newswire Association LLC. - 04 Mar 2024

Procare Health: Silencing HPV infection may exacerbate the physiological effects of the emotional burden

Read more ››
By: PR Newswire Association LLC. - 04 Mar 2024

Tali AI: Revolutionizing Healthcare in the US with AI Technology

Read more ››
By: PR Newswire Association LLC. - 04 Mar 2024

Sandoz acquires CIMERLI® business from Coherus, further building biosimilar and ophthalmology leadership in US market

Read more ››
By: GlobeNewswire - 04 Mar 2024

Coherus Completes Divestiture of Ophthalmology Franchise

Read more ››
By: GlobeNewswire - 04 Mar 2024
Related companies:  Coherus BioSciences, Inc.

Valneva to Present at Upcoming TD Cowen and Van Lanschot Kempen Healthcare Investor Conferences

Read more ››
By: GlobeNewswire - 04 Mar 2024
Related companies:  Valneva SE

Vivoryon Therapeutics N.V. Provides Update on VIVIAD Phase 2b Study of Varoglutamstat in Early Alzheimer’s Disease

Read more ››
By: GlobeNewswire - 04 Mar 2024
Related companies:  Vivoryon Therapeutics N.V.

KSrelief: Successful surgical separation is just the beginning for Nigerian conjoined twins

Read more ››
By: PR Newswire Association LLC. - 04 Mar 2024

Caliway Announced Orphan Drug Designation Granted to CBL-514 for the Treatment of Dercum's Disease

Read more ››
By: PR Newswire Association LLC. - 04 Mar 2024
Related companies:  Caliway Biopharmaceuticals Co., Ltd.

Hugel Receives U.S. FDA Approval for Its Botulinum Toxin Letybo

Read more ››
By: PR Newswire Association LLC. - 04 Mar 2024
Related companies:  Hugel, Inc.

Astellas Initiates Phase 3 Clinical Studies of Fezolinetant for VMS Associated with Menopause in Japan

Read more ››
By: PR Newswire Association LLC. - 04 Mar 2024
Related companies:  Astellas Pharma Inc.

Sleep Apnea Symptoms Linked to Memory and Thinking Problems

Read more ››
By: PR Newswire Association LLC. - 04 Mar 2024

Ibogaine by David Dardashti Creates Innovative Algorithm for Fentanyl Treatment

Read more ››
By: GlobeNewswire - 03 Mar 2024

Ibogaine By David Dardashti Announces Breakthrough Algorithm to Quantify Quantum Electrodynamics

Read more ››
By: GlobeNewswire - 03 Mar 2024

Ibogaine By David Dardashti Visits Ohio to Explore Economic Benefits

Read more ››
By: GlobeNewswire - 03 Mar 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTech SE of Class Action Lawsuit and Upcoming Deadlines - BNTX

Read more ››
By: PR Newswire Association LLC. - 03 Mar 2024

Scilex Holding Company Announces that the Official Committee of Unsecured Creditors of Sorrento Therapeutics, Inc., has Filed a Motion with the U.S. Bankruptcy Court to Extend the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorr

Read more ››
By: GlobeNewswire - 02 Mar 2024

Ultimovacs announces publication of results from NIPU Phase II trial with UV1 vaccination in mesothelioma in European Journal of Cancer

Read more ››
By: GlobeNewswire - 02 Mar 2024
Related companies:  Ultimovacs ASA

Mindpath Health releases Surviving Super Tuesday: How Election Season Can Affect Mental Health and What To Do About It

Read more ››
By: PR Newswire Association LLC. - 02 Mar 2024

Honey & Barry Sherman Legacy Foundation donates $1 million to Scarborough Health Network to innovate diagnostic imaging

Read more ››
By: PR Newswire Association LLC. - 02 Mar 2024
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑